PHENOTYPIC RESISTANCE PROFILES OF SALMONELLA ENTERICA ISOLATED FROM WILD FELIDS IN COSTA RICA BETWEEN 2021 AND 2022.

Salmonella spp. are one of the leading causes of illness, and in the last years there is an increasing interest in the role of different wild animals as reservoir of Salmonella enterica, especially multidrug resistant strains. To establish preventive and action strategies, it is essential to monitor bacterial resistance profiles and systematically collect information. This study aims to report Salmonella enterica and their resistance profile isolated from feces of wild felids that receive veterinary cares by the Hospital de Especies Menores y Silvestres, Costa Rica in 2021 and 2022. Overall, 100% (7/7) of Salmonella spp. isolates exhibited resistance against cefazoline, followed by 71% (5/7) to ciprofloxacin, and 43% (3/7) to nitrofurantoin. A single isolate was found to be multidrug resistant against Ampicillin/Sulbactam-Cefazolin-Ceftriaxone-Gentamicin-Ciprofloxacin-Nitrofurantoin. These resistant profiles highlight that Salmonella enterica isolation can represent a threat to public health and wildlife conservation, especially for those organisms expressing resistant phenotypes to drugs commonly used in clinical settings. Fluoroquinolone resistant Salmonella spp. have been called by the World Health Organization a high priority for research. As these organisms are expanding beyond livestock and hospital associated environments, to understand the epidemiology and impact of fluoroquinolone-resistant Salmonella spp. we require a One Health approach.